United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c switzerland - 36's (12's blister x 3) - lozenge - 1mg / lozenge - central nervous system-substance dependence

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 2513.6 microgram (equivalent: fentanyl, qty 1600 microgram) - lozenge with integral application - excipient ingredients: citric acid; starch sodium octenyl succinate; dextrates; dibasic sodium phosphate; magnesium stearate; shellac; brilliant blue fcf; flavour; maize starch; sucrose - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 1885.2 microgram (equivalent: fentanyl, qty 1200 microgram) - lozenge with integral application - excipient ingredients: starch sodium octenyl succinate; dibasic sodium phosphate; dextrates; citric acid; magnesium stearate; shellac; brilliant blue fcf; flavour; maize starch; sucrose - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 1256.8 microgram (equivalent: fentanyl, qty 800 microgram) - lozenge with integral application - excipient ingredients: citric acid; dibasic sodium phosphate; starch sodium octenyl succinate; dextrates; magnesium stearate; shellac; brilliant blue fcf; flavour; maize starch; sucrose - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 942.6 microgram (equivalent: fentanyl, qty 600 microgram) - lozenge with integral application - excipient ingredients: starch sodium octenyl succinate; dextrates; magnesium stearate; dibasic sodium phosphate; citric acid; shellac; brilliant blue fcf; maize starch; sucrose; flavour - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 628.4 microgram (equivalent: fentanyl, qty 400 microgram) - lozenge with integral application - excipient ingredients: dibasic sodium phosphate; magnesium stearate; starch sodium octenyl succinate; dextrates; citric acid; shellac; brilliant blue fcf; flavour; maize starch; sucrose - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 314.2 microgram (equivalent: fentanyl, qty 200 microgram) - lozenge with integral application - excipient ingredients: dibasic sodium phosphate; citric acid; dextrates; starch sodium octenyl succinate; magnesium stearate; shellac; brilliant blue fcf; flavour; maize starch; sucrose - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Malta - English - Medicines Authority

uni-pharma kleon tsetis pharmaceutical laboratories s.a. 14th km national road athens - lamia 1, gr-145 64 kifissia, greece - lozenge - flurbiprofen 8.75 mg - throat preparations

Malta - English - Medicines Authority

geiser pharma, s.l. camino labiano 45b, 31192 multiva (navarra), , spain - ambroxol hydrochloride - lozenge - ambroxol hydrochloride 20 mg - throat preparations

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

inova pharmaceuticals (pty) ltd - lozenges - see ingredients - each lozenge contains benzydamine hydrochloride 3,0 mg